SZM-1209 is an Orally Active RIPK1 Inhibitor with Anti-SIRS and Anti-ALI Effects
Receptor-interacting protein (RIP) kinases are a group of threonine/serine protein kinases. There are seven members of the RIPK family, RIPK1-7. RIP kinases are cellular signaling molecules that are critical for…